83 related articles for article (PubMed ID: 21452982)
21. Predictive model of blood-brain barrier penetration of organic compounds.
Ma XL; Chen C; Yang J
Acta Pharmacol Sin; 2005 Apr; 26(4):500-12. PubMed ID: 15780201
[TBL] [Abstract][Full Text] [Related]
22. A simple predictive model for blood-brain barrier penetration.
Fu XC; Song ZF; Fu CY; Liang WQ
Pharmazie; 2005 May; 60(5):354-8. PubMed ID: 15918585
[TBL] [Abstract][Full Text] [Related]
23. Escape from flatland: increasing saturation as an approach to improving clinical success.
Lovering F; Bikker J; Humblet C
J Med Chem; 2009 Nov; 52(21):6752-6. PubMed ID: 19827778
[TBL] [Abstract][Full Text] [Related]
24. Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: potent inhibitors of the IGF-1R receptor tyrosine kinase.
Chamberlain SD; Wilson JW; Deanda F; Patnaik S; Redman AM; Yang B; Shewchuk L; Sabbatini P; Leesnitzer MA; Groy A; Atkins C; Gerding R; Hassell AM; Lei H; Mook RA; Moorthy G; Rowand JL; Stevens KL; Kumar R; Shotwell JB
Bioorg Med Chem Lett; 2009 Jan; 19(2):469-73. PubMed ID: 19056263
[TBL] [Abstract][Full Text] [Related]
25. Fragment-based discovery of JAK-2 inhibitors.
Antonysamy S; Hirst G; Park F; Sprengeler P; Stappenbeck F; Steensma R; Wilson M; Wong M
Bioorg Med Chem Lett; 2009 Jan; 19(1):279-82. PubMed ID: 19019674
[TBL] [Abstract][Full Text] [Related]
26. Fragment analysis in small molecule discovery.
Merlot C; Domine D; Church DJ
Curr Opin Drug Discov Devel; 2002 May; 5(3):391-9. PubMed ID: 12058614
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model.
Grant S; Tran P; Zhang Q; Zou A; Dinh D; Jensen J; Zhou S; Kang X; Zachwieja J; Lippincott J; Liu K; Johnson SL; Scales S; Yin C; Nukui S; Stoner C; Prasanna G; Lafontaine J; Wells P; Li H
Eur J Pharmacol; 2010 Feb; 627(1-3):16-25. PubMed ID: 19850035
[TBL] [Abstract][Full Text] [Related]
28. Desirability-based methods of multiobjective optimization and ranking for global QSAR studies. Filtering safe and potent drug candidates from combinatorial libraries.
Cruz-Monteagudo M; Borges F; Cordeiro MN; Cagide Fajin JL; Morell C; Ruiz RM; Cañizares-Carmenate Y; Dominguez ER
J Comb Chem; 2008; 10(6):897-913. PubMed ID: 18855460
[TBL] [Abstract][Full Text] [Related]
29. Discovery and optimization of pyrazoline compounds as B-Raf inhibitors.
Duffey MO; Adams R; Blackburn C; Chau RW; Chen S; Galvin KM; Garcia K; Gould AE; Greenspan PD; Harrison S; Huang SC; Kim MS; Kulkarni B; Langston S; Liu JX; Ma LT; Menon S; Nagayoshi M; Rowland RS; Vos TJ; Xu T; Yang JJ; Yu S; Zhang Q
Bioorg Med Chem Lett; 2010 Aug; 20(16):4800-4. PubMed ID: 20634068
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 6-aryl-7-alkoxyisoquinoline inhibitors of IkappaB kinase-beta (IKK-beta).
Christopher JA; Bamborough P; Alder C; Campbell A; Cutler GJ; Down K; Hamadi AM; Jolly AM; Kerns JK; Lucas FS; Mellor GW; Miller DD; Morse MA; Pancholi KD; Rumsey W; Solanke YE; Williamson R
J Med Chem; 2009 May; 52(9):3098-102. PubMed ID: 19348415
[TBL] [Abstract][Full Text] [Related]
31. Recent patents in the discovery of small molecule inhibitors of JAK3.
Wilson LJ
Expert Opin Ther Pat; 2010 May; 20(5):609-23. PubMed ID: 20402545
[TBL] [Abstract][Full Text] [Related]
32. In silico exploration for identifying structure-activity relationship of MEK inhibition and oral bioavailability for isothiazole derivatives.
Melagraki G; Afantitis A; Sarimveis H; Igglessi-Markopoulou O; Koutentis PA; Kollias G
Chem Biol Drug Des; 2010 Nov; 76(5):397-406. PubMed ID: 20925691
[TBL] [Abstract][Full Text] [Related]
33. Development and use of hydrophobic surface area (HSA) descriptors for computer-assisted quantitative structure-activity and structure-property relationship studies.
Stanton DT; Mattioni BE; Knittel JJ; Jurs PC
J Chem Inf Comput Sci; 2004; 44(3):1010-23. PubMed ID: 15154770
[TBL] [Abstract][Full Text] [Related]
34. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
Edwards PJ
Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development.
Wittman MD; Carboni JM; Yang Z; Lee FY; Antman M; Attar R; Balimane P; Chang C; Chen C; Discenza L; Frennesson D; Gottardis MM; Greer A; Hurlburt W; Johnson W; Langley DR; Li A; Li J; Liu P; Mastalerz H; Mathur A; Menard K; Patel K; Sack J; Sang X; Saulnier M; Smith D; Stefanski K; Trainor G; Velaparthi U; Zhang G; Zimmermann K; Vyas DM
J Med Chem; 2009 Dec; 52(23):7360-3. PubMed ID: 19778024
[TBL] [Abstract][Full Text] [Related]
36. Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening.
Usui T; Ban HS; Kawada J; Hirokawa T; Nakamura H
Bioorg Med Chem Lett; 2008 Jan; 18(1):285-8. PubMed ID: 17983745
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
[TBL] [Abstract][Full Text] [Related]
38. Prediction of intestinal absorption and blood-brain barrier penetration by computational methods.
Clark DE
Comb Chem High Throughput Screen; 2001 Sep; 4(6):477-96. PubMed ID: 11562253
[TBL] [Abstract][Full Text] [Related]
39. Assessing the impact of generative AI on medicinal chemistry.
Walters WP; Murcko M
Nat Biotechnol; 2020 Feb; 38(2):143-145. PubMed ID: 32001834
[No Abstract] [Full Text] [Related]
40. Computational chemistry: Making a bad calculation.
Winter A
Nat Chem; 2015 Jun; 7(6):473-5. PubMed ID: 25991524
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
